Efficacy of S-1 in patients with capecitabine-resistant breast cancer-Japan Breast Cancer Research Network (JBCRN) 04-1 trial.
Yamamoto
D
D
Department of Surgery, Kansai Medical University, Hirakata, Osaka 570-8507, Japan. yamamotd@hirakata.ac.jp
Iwase
S
S
Yoshida
H
H
Kuroda
Y
Y
Yamamoto
C
C
Kitamura
K
K
Odagiri
H
H
Nagumo
Y
Y